Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study
Urun, Yuksel, Yasar, H Arzu, Turna, Hande, Esin, Ece, Sedef, A Murat, Alkan, Ali, Oksuzoglu, Berna, Ozdemir, Nuriye, Sendur, Ma Nahit, Sezer, Ahmet, Kılıckap, Saadettin, Utkan, Gungor, Akman, Tulay, Akbulut, Hakan, Celik, Ismail, Abalı, Huseyin
Published in Journal of oncology pharmacy practice (01.10.2019)
Published in Journal of oncology pharmacy practice (01.10.2019)
Get more information
Journal Article
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study
Arzu Yaşar, H, Turna, Hande, Esin, Ece, Murat Sedef, A, Alkan, Ali, Oksuzoglu, Berna, Ozdemir, Nuriye, Sendur, Ma Nahit, Sezer, Ahmet, Kılıckap, Saadettin, Utkan, Gungor, Akbulut, Hakan, Celik, Ismail, Abalı, Huseyin, Urun, Yuksel
Published in Journal of oncology pharmacy practice (01.03.2020)
Published in Journal of oncology pharmacy practice (01.03.2020)
Get more information
Journal Article
Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?
Ürün, Yüksel, Yaşar, H Arzu, Turna, Hande, Kılıçkap, Saadettin, Sezer, Ahmet, Öksüzoğlu, Berna, Özdemir, Nuriye, Şendur, Ma Nahit, Abalı, Hüseyin
Published in Journal of oncology pharmacy practice (01.12.2019)
Published in Journal of oncology pharmacy practice (01.12.2019)
Get more information
Journal Article
EE193 The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey
Akpamuk, U, Hughes, R, Swales, O, Oyan, B, Kilickap, S, Demirci, U, Sendur, MA, Sonmez, O, Yazici, O, Malhan, S, Oksuz, E, Tuzer, E, Akyol Ersoy, B, Poellinger, B
Published in Value in health (01.07.2022)
Published in Value in health (01.07.2022)
Get full text
Journal Article